PeptideStack
5.2kquestions
20kanswers
220users

Does holding at 40 mg for twelve weeks before escalating reduce constipation?

Asked 22 Mar 2024Modified 2.4 years agoViewed 53k times
36

Conditions: 40 mg · twelve weeks · constipation.

I want to know whether this is a real physical effect or an artefact of how it is measured.

What prompted the question is an inconsistency between two sources I otherwise trust.

Why does this happen, and what would falsify the usual explanation?

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

444 questionsnausea
nausea

The dominant tolerability signal in every trial of the class: incidence, timing relative to a dose step, duration, and the distinction between…

346 questionsdose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

88 questions
shareeditfollowflag
LW
askedlinnea_wahlberg14k1822 Mar 2024
4Two of us worked through this independently and arrived here, so it is at least reproducible. – tare_and_weigh 4 months ago
3Worth adding that the method section is where the answer usually is. – Dr_Hanne_Solberg 2 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 53k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.